Back

Basic science and mechanism of action of lipoprotein(a).

26 August 2018 (13:00 - 13:17)
Organised by:
Congress Presentation Part of: Cardiovascular risk reduction and the role of lipoprotein(a): present and future therapeutic options Lipids ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Sotirios Tsimikas

University of California San Diego, La Jolla (United States of America)

3 More presentations in this session

Presentation thumbnail
Epidemiology and clinical trial data of lipoprotein(a).
Doctor L. Cho (Cleveland, US)
Presentation thumbnail
Current and future treatment strategies to lower lipoprotein(a) .
Professor S. Nissen (Cleveland, US)
Presentation thumbnail
Panel discussion and Q&A.

Access the full session

Session thumbnail
Cardiovascular risk reduction and the role of lipoprotein(a): present and future therapeutic options

The Event

Event poster

ESC Congress 2018

26 August 2018 13:00 CET
You may be interested in
thumbnail
Webinar
Lipoprotein(a): current role and future perspectives in cardiovascular medicine
31 October 2025
thumbnail
Congress Presentation
Lp(a) impairs NK cell function potentially contributes to impaired immunity and increased cardiovascular disease risk
28 August 2026
thumbnail
Congress Presentation
Review on clinical strategies for managing patients with elevated Lp(a): Cost-effectiveness of Lp(a) testing and awareness of lifestyle changes via Public Health Policy in absence of targeted therapy
24 June 2023
thumbnail
Congress Presentation
Discovery and preclinical development of LY3473329, a potent small molecule inhibitor of lipoprotein(a) formation
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources